key articles

Wednesday, 15 May 2013-  Continence post robotic assisted laparoscopic radical prostatectomy (RALP) is approximately 90% and many reconstructive techniques have been described to improve early continence.

T. T. Shah anc...

Tuesday, 7 May 2013- Prostate-specific antigen (PSA) testing for prostate cancer screening should proceed only after careful discussion of risks and harms with patients, and should target men ages 55 to 69, according to the...

Thursday, 2 May 2013- Intermittent androgen deprivation appears to be just as hard on relapsing or advanced prostate cancer as continuous dosing but easier on patients, a meta-analysis showed.

None of the nine studies comparing...

Tuesday, 30 April 2013- Previously, the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-CaP) questionnaire and/or the physician-reported Charlson Comorbidity Index (CCI) have provided assessments of...

Monday, 29 April 2013- With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine....

Thursday, 25 April 2013- Four new therapies have been recently approved for the treatment of men with castration-resistant prostate cancer; still, more treatment options are needed.

A.Tewari and colleagues wrote a review which...

Wednesday, 24 April 2013- Localized prostate cancer with two types of genetic abnormalities had a 50 times greater risk of fatal recurrence after prostatectomy than did tumors without the alterations, a multicentre research group...

Tuesday, 23 April 2013- Better outcomes can be achieved for prostate cancer patients using brachytherapy, a highly targeted form of radiotherapy, compared to surgery - this is the finding of a new study conducted by PANAXEA, of...

Monday, 22 April 2013- Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published this week on...

Friday, 19 April 2013- Prostate cancer (PCa) is the second leading cause of cancer deaths in men in the United States. The prostate-specific antigen (PSA), often found at high levels in the serum of PCa patients, has been used as...